CN112587611A - Antihypertensive composition and application thereof - Google Patents

Antihypertensive composition and application thereof Download PDF

Info

Publication number
CN112587611A
CN112587611A CN202011464137.4A CN202011464137A CN112587611A CN 112587611 A CN112587611 A CN 112587611A CN 202011464137 A CN202011464137 A CN 202011464137A CN 112587611 A CN112587611 A CN 112587611A
Authority
CN
China
Prior art keywords
parts
antihypertensive
patch
powder
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011464137.4A
Other languages
Chinese (zh)
Inventor
陈玉祥
刘忠强
陈扬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changsha Qingyaling Health Management Co ltd
Original Assignee
Changsha Qingyaling Health Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changsha Qingyaling Health Management Co ltd filed Critical Changsha Qingyaling Health Management Co ltd
Priority to CN202011464137.4A priority Critical patent/CN112587611A/en
Publication of CN112587611A publication Critical patent/CN112587611A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides an antihypertensive composition and application thereof. An antihypertensive composition comprises fructus Jujubae, exocarpium Benincase, rhizoma Polygonati, semen Cassiae, ramulus Uncariae cum uncis, flos Chrysanthemi, Ginseng radix, Cordyceps militaris, Carthami flos and Moschus. Compared with oral administration, the antihypertensive patch containing the antihypertensive composition adopts a transdermal administration form, has small toxic and side effects on patients, and is safe and convenient to use; the antihypertensive patch combines drug permeation and body surface heating, so that the curative effect is more stable and lasting; when the acupuncture effect is achieved, the blood pressure lowering effect is better by combining transdermal administration, and the pain risk of acupuncture is avoided. The antihypertensive patch provided by the invention has good antihypertensive effect: after one week of patient use, the blood pressure of the patient decreased to the normal range.

Description

Antihypertensive composition and application thereof
Technical Field
The invention belongs to the field of Chinese herbal medicines, and particularly relates to an antihypertensive composition and application thereof.
Background
The Chinese cardiovascular disease report 2018 indicates that 2.9 million patients with cardiovascular diseases exist in China, wherein 2.45 million patients with hypertension account for about 84.5 percent of the total number of patients. Hypertension is complicated with high-risk diseases such as cerebral apoplexy, left ventricular hypertrophy, angina pectoris, myocardial infarction, heart failure, hypertensive renal injury, hypertension fundus damage and the like besides symptoms such as headache, dizziness, tinnitus, palpitation and the like. Due to the large patient base and serious complications, hypertension has become an epidemic disease seriously threatening the physical health of people.
Traditional Chinese medicine classifies hypertension into four types. (1) Hyperactivity of liver yang with symptoms of vertigo, tinnitus, distending pain of head, flush face, sharp noise, irritability, less sleep, dreaminess, bitter taste, red tongue, yellow tongue fur, wiry pulse, and vexation and anger aggravation; (2) stagnation of turbid phlegm in the middle energizer manifested by vertigo, heaviness of the head, chest distress, nausea, even vomiting, phlegm, saliva, poor appetite, somnolence, white and greasy tongue coating, and soft and smooth pulse; (3) deficiency of qi and blood, manifested by vertigo, fatigue, aggravation of movement, lusterless complexion, palpitation, insomnia, pale lips and nails, short breath, fatigue, no speaking desire, diet deficiency, pale tongue, and thready and weak pulse; (4) the symptoms of kidney essence deficiency include vertigo, listlessness, insomnia, dreaminess, amnesia, soreness of waist and knees, spermatorrhea, and tinnitus.
Aiming at different symptoms, patients need to take different antihypertensive oral medicines for a long time, and the antihypertensive effect of the oral medicines is good, but the side effect is obvious. For example, the diuretic hydrochlorothiazide can cause a decrease in blood potassium, an increase in uric acid, male erectile dysfunction or hyposexuality; angiotensin converting enzyme inhibitors (ACEI drugs, such as captopril) cause hypotension, hyperkalemia, cough, angioedema, and renal function deterioration in the first dose; angiotensin II receptor antagonists can cause dizziness, cough, and weakness; calcium antagonists may also cause headache, edema, flushing, etc.; side effects of beta-blockers include bronchial, heart failure, atrioventricular block, bradycardia, glycolipid metabolic disorders; the side effects of alpha 1 receptor blockers include first dose phenomena, severe orthostatic hypotension, dizziness, palpitations, and rapid drug resistance phenomena.
In conclusion, hypertension is treated only slowly, but oral medicines can bring partial toxic and side effects, and the medicines need to be taken for a lifetime, which brings inconvenience to life of patients.
Disclosure of Invention
The present invention is directed to solving at least one of the above problems in the prior art. Therefore, the invention provides an antihypertensive composition.
The invention also provides an application of the antihypertensive composition.
An antihypertensive composition comprises fructus Jujubae, exocarpium Benincase, rhizoma Polygonati, semen Cassiae, ramulus Uncariae cum uncis, flos Chrysanthemi, Ginseng radix, Cordyceps militaris, Carthami flos and Moschus.
According to some embodiments of the invention, the antihypertensive composition comprises, by weight, 4-6 parts of Chinese date, 4-6 parts of exocarpium benincasae, 9-11 parts of rhizoma polygonati, 9-11 parts of semen cassiae, 14-16 parts of uncaria, 9-11 parts of chrysanthemum, 9-11 parts of ginseng, 14-16 parts of cordyceps militaris, 9-11 parts of safflower and 9-11 parts of musk.
According to some embodiments of the present invention, the antihypertensive composition includes, by weight, 5 parts of jujube, 5 parts of exocarpium benincasae, 10 parts of rhizoma polygonati, 10 parts of semen cassiae, 15 parts of uncaria, 10 parts of chrysanthemum, 10 parts of ginseng, 15 parts of cordyceps militaris, 10 parts of safflower, and 10 parts of musk.
Cordycepic acid (D-mannitol) and adenosine contained in Cordyceps militaris can be used for preventing/treating cerebral thrombosis, cerebral hemorrhage, and renal failure, and also has diuretic effect.
The ginsenoside contained in Ginseng radix has two-way regulating effect on blood pressure according to dosage and organism function state. A small dose of ginseng increases blood pressure, and a large dose of ginseng decreases blood pressure. Ginseng also contains volatile oil, multiple organic acids, and ginseng acid, and has blood vessel dilating and blood pressure lowering effects. The effective components in Ginseng radix can block M-choline receptor, activate alpha 2 receptor of presynaptic membrane, and reduce dilution of sympathetic transmitter to lower blood pressure.
The cassia seed belongs to the liver channel and the large intestine channel, so the cassia seed has the effects of clearing heat and improving eyesight and relaxing bowel, is mainly used for treating red and swollen eyes, pain, blurred vision, headache and dizziness, intestinal dryness and constipation and other symptoms caused by liver channel heat and liver fire flaming up clinically, and has obvious effect. Can be used as pillow filler, and also has effects in clearing away heat and purging pathogenic fire.
In animal experiments, the cassia seed has obvious effect of reducing the blood pressure of animals, and also has obvious effect of reducing the blood pressure clinically.
In addition, the cassia seed can also reduce blood fat, and has obvious effect of reducing blood fat after long-term use.
Huang Jing is sweet in flavor, neutral in nature and non-toxic, and belongs to the lung, spleen and kidney meridians. The efficacy and the effect are as follows:
1. rhizoma Polygonati has effects of invigorating spleen and replenishing qi, and can be used for treating spleen and stomach weakness, listlessness, abdominal distention, anorexia caused by stomach yin deficiency, and xerostomia;
2. rhizoma Polygonati has effects of invigorating lung yin, especially for patients with dry cough, little phlegm, cough and bloody blood caused by lung dryness;
3. rhizoma Polygonati has effects of invigorating kidney yin, and can be used for treating soreness of waist, asthenia, dysphoria with smothery sensation in chest, premature graying of hair, diabetes due to yin deficiency and internal heat, and xerostomia due to stomach heat;
4. contraindications of rhizoma polygonati: people with deficiency-cold of middle energizer, diarrhea, phlegm-dampness and fullness, qi stagnation and poor appetite should not take the medicine.
The exocarpium Benincase is the outer layer of dried exocarpium Benincase of Cucurbitaceae. The exocarpium Benincase is cool in nature, can clear away summer-heat, and can be used for treating thirst, scanty and brownish urine, and edema caused by summer-heat in summer.
The Chinese date has the following effects:
1. the red dates have an important effect on preventing and treating osteoporosis and anemia;
2. the content of vitamin C in the red dates is the crowns of all fruits and vegetables, and the red dates have the effects of maintaining capillary permeability and improving microcirculation so as to prevent arteriosclerosis;
3. the fructus Jujubae can promote leukocyte generation, reduce serum cholesterol, and protect liver, and also contains substances for inhibiting cancer cell development and even converting cancer cell into normal cell.
The dry flowers of Carthamus tinctorius L of Compositae have pungent and warm nature, and enter heart and liver meridians, and have effects of promoting blood circulation, dredging channels, removing blood stasis and relieving pain. Can be used for treating amenorrhea, dysmenorrhea, lochiorrhea, abdominal mass, thoracic obstruction, cardialgia, abdominal pain due to blood stasis, pain in chest and hypochondrium, traumatic injury, and pyocutaneous disease with swelling and pain.
Safflower has the property of pungent, warm and unblocking, has the functions of promoting blood circulation to remove meridian obstruction, eliminating blood stasis and relieving pain, is a medicine for promoting blood circulation to remove blood stasis and is widely used for blood stasis of various internal, external, gynecological and traumatic families.
Moschus has bidirectional effect on central nervous system, and has exciting effect on epinephrine and beta receptor in peripheral blood vessel. Moschus also has antiinflammatory, analgesic, and heart tonifying effects, and the suspension can be used for preventing and treating gastric ulcer. Moschus has effect in resisting early pregnancy.
The chrysanthemum is sweet and bitter in taste, slightly cold in flavor, enters lung and liver meridians, and has the main effects and effects of dispelling wind and heat, calming the liver, improving eyesight, clearing heat and removing toxicity.
The uncaria is taken as a medicine by dry stems with hooks, has the functions of calming, reducing blood pressure, clearing heat and calming the liver, calming wind and arresting convulsion, is used for treating headache, dizziness, common cold with convulsion, epilepsy, convulsion, pregnancy, eclampsia, hypertension and other symptoms, is one of the first-choice medicinal materials for treating cardiovascular and cerebrovascular diseases, and has a long clinical application history.
Pharmacological action of uncaria: 1. sedation: has certain inhibition effect on the excitability increasing state of the central motility analyzer. Rhynchophylline is an indole derivative, so that rhynchophylline can have a specific effect on the spirit. 2. The function of reducing blood pressure: the rhynchophylline has obvious effect of reducing blood pressure.
According to some embodiments of the invention, the antihypertensive composition is in powder form.
An antihypertensive patch containing the antihypertensive composition comprises the antihypertensive composition and a patch body,
the base lining layer is a medical adhesive tape;
a therapeutic layer, the components of which comprise the antihypertensive composition or extract thereof;
the isolation layer is made of single-layer silicone oil paper;
and the covering layer is made of single-layer silicone oil paper.
When in use, the covering layer is taken off, the rest part is attached to the hypertension acupuncture points, and one side surface of the isolating layer is directly attached to the skin.
According to some embodiments of the invention, the antihypertensive patch is square in shape with a side length of 7.5 cm.
According to some embodiments of the invention, in the antihypertensive patch, the weight of the antihypertensive composition is 5 to 7 g.
In the antihypertensive patch, the quality of the antihypertensive composition is 20 times that of a common patch, and the medicinal effect is more durable under a specific transdermal administration speed and can reach 2-3 days.
According to some embodiments of the invention, the therapeutic layer of the anti-hypertensive patch further comprises a transdermal agent.
According to some embodiments of the invention, the transdermal agent is at least one of menthol, eucalyptus oil, ethanol and glycerol.
According to some embodiments of the present invention, in the antihypertensive patch, the transdermal agent is used in an amount of 1 to 3 parts by mass.
The transdermal agent has the first function of expanding epidermal intercellular spaces and pores to promote penetration of the drug into the skin of a human body and then into the body.
The second aspect of the transdermal agent is used as a solvent to be mixed with the powdery antihypertensive composition extract to be prepared into a paste, so as to ensure the effect of the drug in the antihypertensive patch.
According to some embodiments of the invention, the therapeutic layer of the anti-hypertension paste further comprises far infrared ceramic powder.
The far infrared ceramic powder can radiate far infrared rays, and can heat the attached acupuncture points of the antihypertensive patch at constant temperature, so that the blood circulation is promoted, and the absorption and the drug effect of the antihypertensive composition are promoted.
According to some embodiments of the invention, the therapeutic layer of the anti-hypertensive paste further comprises permanent magnetic sheets.
According to some preferred embodiments of the invention, the permanent magnet pieces are sintered rubidium iron boron permanent magnet pieces.
Each magnetic sheet of the magnetic field is a magnetic source, and the permanent magnetic sheets can form a magnetic field and act on acupuncture points to achieve acupuncture point therapy.
The antihypertensive composition, the transdermal agent, the permanent magnetic sheet and the far infrared ceramic powder in the antihypertensive patch are matched with each other and act on the attached position together, so that the antihypertensive patch can play roles in adjusting yin and yang, dredging channels and collaterals, harmonizing ying and wei, tonifying deficiency and relieving excess, and activating blood and dissolving stasis.
The balance of yin and yang, which is the basis of health, of the human body; the antihypertensive patch is attached to acupuncture points, and can regulate mental stress, dilate blood vessels and restore the normal state.
The dredging of the channels and collaterals can cause diseases when the channels and collaterals are not communicated, and the channels and collaterals can show different symptoms of body parts, such as pain, numbness, muscle tension, spasm and vasoconstriction of different parts of the body; the antihypertensive patch can dredge channels and collaterals, regulate muscle nerves and eliminate tension and spasm of muscle tissues.
When the nutrient and defensive qi are harmonized and the nutrient and defensive qi are not matched, qi and blood circulation is obstructed, or the six exogenous pathogenic factors are induced by internal injury of seven emotions, meridian blockage and blood pressure are increased; the anti-hypertension patch can coordinate ying and wei and control blood pressure.
The blood circulation is activated to dissipate blood stasis, and the internal stagnation of blood stasis can cause pathological changes of viscera or body; the anti-hypertension patch can accelerate local blood circulation, reduce the flow resistance of blood, promote blood circulation to remove blood stasis, improve and strengthen the cardiac function, accelerate the establishment of microcirculation and regulate hypertension.
Compared with oral administration, the antihypertensive patch provided by the invention reduces the puncture of the medicament to intestines and stomach and avoids the first pass effect of the medicament on the liver by adopting external transdermal administration, so that the antihypertensive patch has small side effect and is safe to use.
The anti-hypertension patch provided by the invention does not bubble and is not allergic in the using process.
An application of an antihypertensive patch containing the antihypertensive composition in the field of hypertension treatment.
According to some embodiments of the invention, the method comprises: the antihypertensive patch is attached to a specific acupuncture point, a reflex area or a pain part of a human body.
The specific acupoints include DAZHUI acupoint, Taiyang acupoint, QUZE acupoint, NEIGUAN acupoint, SANYIJIAO acupoint, TAICHONG acupoint, Zusanli acupoint and YONGQUAN acupoint.
According to some embodiments of the present invention, the anti-hypertension patch can be used alone or together with food for regulating hypertension.
The food for regulating hypertension comprises:
the ginseng medlar solid beverage bag: the main components are medicinal materials or food materials with homology of medicine and food, such as ginseng, medlar, kudzu root, yam, oyster, cordyceps militaris, cinnamon, Chinese date, chrysanthemum, hawthorn, corn stigma, coix seed, white gourd, sealwort, cassia seed, balsam pear, mint and the like, or water and ethanol extracts of the medicinal materials and the food materials with homology of medicine and food;
the white gourd and coix seed meal bag comprises: the main ingredients are five cereals such as oat, wax gourd and coix seed, and each bag is 20 g; the ginseng medlar solid beverage is added every time the bread is eaten, wherein the adding amount of the ginseng medlar solid beverage is 1-10% of the mass of the wax gourd coix seed meal bag;
milk product: adding at least one of milk or soymilk into the ginseng medlar solid beverage every time of drinking, wherein the addition amount of the ginseng medlar solid beverage is 1-10% of the mass of the milk product;
tea bag making: at least one of Yunnan black tea, Biluochun green tea and Hunan Shaoyang Taohouning cyclocarya paliurus, wherein each bag is 2-3g in mass, 2-2.5 g of the tea is tea, and 0.5-1 g of ginseng and medlar solid powder.
Compared with the prior art, the invention has at least the following beneficial effects.
(1) Compared with oral administration, the antihypertensive patch containing the antihypertensive composition provided by the invention adopts transdermal administration, avoids stimulation to intestines and stomach of a patient, and is small in toxic and side effects to the patient and safe to use.
(2) Compared with oral administration, the antihypertensive patch containing the antihypertensive composition combines far infrared magnetic therapy technology and transdermal administration, so that the medicine on the antihypertensive patch can permeate into a human body at a constant speed and for a long time, and the first pass effect of the liver is avoided, so that the curative effect is more stable and lasting.
(3) Compared with acupuncture and moxibustion therapy, the antihypertensive patch containing the antihypertensive composition provided by the invention has the advantages that the antihypertensive effect is achieved, the antihypertensive effect is better by combining transdermal administration, and the pain risk of acupuncture and moxibustion is avoided.
(4) The antihypertensive patch containing the antihypertensive composition provided by the invention has good antihypertensive effect: after one week of patient use, the blood pressure of the patient decreased to the normal range.
Detailed Description
The following are specific examples of the present invention, and the technical solutions of the present invention will be further described with reference to the examples, but the present invention is not limited to the examples.
Example 1
The embodiment provides an antihypertensive patch, which comprises a base lining layer, a treatment area, an isolation layer and a covering layer, wherein the base lining layer is sequentially stacked into a whole and made of medical adhesive tapes, the treatment area comprises an antihypertensive composition, a transdermal agent, a permanent magnetic sheet and far infrared ceramic powder, and the isolation layer and the covering layer are made of single-pass silicone oil paper. The antihypertensive composition formulation for the treatment area is shown in table 1, and the components for the treatment area are shown in table 2.
Example 2
The present example provides an anti-hypertensive patch, which is different from example 1 in the components of the treatment region, and the specific components are shown in table 2.
Comparative example 1
The comparative example provides an antihypertensive patch, which is different from example 1 in that the antihypertensive composition and the transdermal agent are not added to the treatment area, and the specific components are shown in table 2.
Comparative example 2
The comparative example provides an antihypertensive patch, which is different from example 1 in that far infrared ceramic powder and permanent magnetic sheets are not added to the treatment area, and the specific components are shown in table 2.
TABLE 1 antihypertensive composition formula in antihypertensive patch of example 1 in parts by mass
Chinese date White gourd peel Rhizome of Siberian solomonseal Cassia seed Ramulus Uncariae cum uncis (Chrysanthemum) Ginseng radix Cordyceps militaris (L.) Link Safflower Musk musk
Example 1 5 5 10 10 15 10 10 15 10 10
Table 2 components of the treatment layer in the antihypertensive patch.
Figure BDA0002833357930000071
Figure BDA0002833357930000081
Wherein "x" indicates no addition and "v" indicates addition.
Application example 1
In the application example, the antihypertensive patches obtained in examples 1 to 2 and comparative examples 1 to 2 are applied to patients with hypertension to test the effect, and the specific application method is as follows.
The application object is: 25 hypertensive patients with the hypertension of 180-190 mmHg, the hypertension of 130-150 mmHg and the age of 45-50 years are selected and randomly and averagely divided into 5 groups of 5 patients each. Four of the four antihypertensive patches obtained in examples 1 to 2 and comparative examples 1 to 2 were applied to four groups, respectively, and the other group was used as a blank control group, using only the blank patch containing no treatment area.
In the application process, each person attaches three positions: dazhui, Quze and Sanyinjiao; each anti-hypertension patch is used for 3 days; the application was carried out for a total of 6 days.
After 6 days of attaching the antihypertensive patch, the patients were observed for changes and tested for blood pressure, and the results are shown in table 3.
Table 3 blood pressure and skin condition after application of the anti-hypertensive patches to patients.
Figure BDA0002833357930000082
Figure BDA0002833357930000091
Wherein "x" represents a no-response phenomenon.
Table 3 the results illustrate that: the anti-hypertension patch provided by the invention has the advantages that (1) in the using process, the skin is not damaged, and adverse phenomena such as allergy, bubbling and the like cannot occur; (2) the blood pressure of a patient with hypertension can be effectively regulated, and the blood pressure condition is basically recovered to be normal after the patient is used for one week; (3) the antihypertensive drug cannot effectively regulate blood pressure without adding the antihypertensive composition or adding the far infrared ceramic powder and the permanent magnetic sheet, and the antihypertensive drug and the far infrared ceramic powder can show good antihypertensive effect by combining the antihypertensive drug and the permanent magnetic sheet.
The present invention has been described in detail with reference to the embodiments, but the present invention is not limited to the embodiments described above, and various changes can be made within the knowledge of those skilled in the art without departing from the gist of the present invention.

Claims (10)

1. An antihypertensive composition is characterized by comprising Chinese date, Chinese waxgourd peel, sealwort, cassia seed, uncaria, chrysanthemum, ginseng, cordyceps militaris, safflower and musk.
2. The antihypertensive composition according to claim 1, wherein the antihypertensive composition comprises, by mass, 4 to 6 parts of jujube powder, 4 to 6 parts of Chinese waxgourd peel powder, 9 to 11 parts of fine yellow powder, 9 to 11 parts of cassia seed powder, 14 to 16 parts of uncaria powder, 9 to 11 parts of chrysanthemum powder, 9 to 11 parts of ginseng powder, 14 to 16 parts of cordyceps militaris powder, 9 to 11 parts of safflower powder and 9 to 11 parts of musk powder.
3. The antihypertensive composition according to claim 1, wherein the antihypertensive composition comprises, by mass, 5 parts of jujube, 5 parts of exocarpium benincasae, 10 parts of rhizoma polygonati, 10 parts of semen cassiae, 15 parts of uncaria, 10 parts of chrysanthemum, 10 parts of ginseng, 15 parts of cordyceps militaris, 10 parts of safflower, and 10 parts of musk.
4. An antihypertensive patch containing the antihypertensive composition according to any one of claims 1 to 3, characterized by comprising the antihypertensive composition and the antihypertensive composition which are sequentially stacked together,
the base lining layer is a medical adhesive tape;
a therapeutic layer, the components of which comprise the antihypertensive composition or extract thereof;
the isolation layer is made of single-layer silicone oil paper;
and the covering layer is made of single-layer silicone oil paper.
5. The anti-hypertensive patch according to claim 4, wherein the weight of the anti-hypertensive composition in each anti-hypertensive patch is 5-7 g.
6. The anti-hypertensive sticker of claim 4, wherein the treatment layer further comprises a transdermal agent.
7. The anti-hypertensive patch according to claim 4, wherein the transdermal agent is at least one of menthol, eucalyptus oil, ethanol, and glycerol.
8. The anti-hypertension patch according to claim 6 or 7, wherein the transdermal agent is used in an amount of 1 to 3 parts by mass per patch.
9. The antihypertensive patch according to claim 4, wherein the therapeutic layer further comprises far infrared ceramic powder.
10. The antihypertensive patch according to claim 1, wherein the therapeutic layer further comprises permanent magnetic sheets.
CN202011464137.4A 2020-12-14 2020-12-14 Antihypertensive composition and application thereof Pending CN112587611A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011464137.4A CN112587611A (en) 2020-12-14 2020-12-14 Antihypertensive composition and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011464137.4A CN112587611A (en) 2020-12-14 2020-12-14 Antihypertensive composition and application thereof

Publications (1)

Publication Number Publication Date
CN112587611A true CN112587611A (en) 2021-04-02

Family

ID=75192614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011464137.4A Pending CN112587611A (en) 2020-12-14 2020-12-14 Antihypertensive composition and application thereof

Country Status (1)

Country Link
CN (1) CN112587611A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998770A (en) * 2006-01-13 2007-07-18 霍德銮 Hypertensor plaster with tranquilizing function
CN102058841A (en) * 2010-12-02 2011-05-18 韩世昌 Medicine for umbilicus external use for treating hypertension and preparation method thereof
CN102389563A (en) * 2011-11-25 2012-03-28 武兴战 Transdermal absorption traditional Chinese medicinal blood pressure protection bag and its preparation method
CN110559419A (en) * 2019-10-11 2019-12-13 张先奇 traditional Chinese medicine composition for preventing and conditioning hypertension and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998770A (en) * 2006-01-13 2007-07-18 霍德銮 Hypertensor plaster with tranquilizing function
CN102058841A (en) * 2010-12-02 2011-05-18 韩世昌 Medicine for umbilicus external use for treating hypertension and preparation method thereof
CN102389563A (en) * 2011-11-25 2012-03-28 武兴战 Transdermal absorption traditional Chinese medicinal blood pressure protection bag and its preparation method
CN110559419A (en) * 2019-10-11 2019-12-13 张先奇 traditional Chinese medicine composition for preventing and conditioning hypertension and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
周万松: "磁疗 ", 《基础医学与临床》 *
秦春美等: "复方降压方穴位贴敷治疗肝阳上亢型高血压病的疗效观察", 《中国继续医学教育》 *
秦春美等: "降压方穴位贴敷治疗肝阳上亢型高血压病的疗效探讨 ", 《中外医疗》 *

Similar Documents

Publication Publication Date Title
CN113521243A (en) Traditional Chinese medicine composition for improving human microcirculation and preparation method thereof
CN104825891A (en) Traditional Chinese medicine preparation for treating epilepsy
CN111249420A (en) Traditional Chinese medicine composition for regulating and treating qi-stagnation constitution and preparation and application thereof
CN105995447A (en) Health-preservation porridge capable of blackening hair and resisting ageing and preparation method of health-preservation porridge
CN112587611A (en) Antihypertensive composition and application thereof
CN105641060A (en) Medicine composition with body building and yang tonifying functions
CN105560894A (en) Traditional Chinese medicine composition for treating allergic cheilitis and preparation method
CN111870630A (en) Medicine formula for enhancing resistance and immunity and preparation process
CN105214035A (en) One treats peptic ulcer tablet and preparation method thereof
CN106177437B (en) Maca composition for improving yang deficiency and body cold of women
CN104840902A (en) Traditional Chinese medicine preparation for treating ovarian tumor
CN104825777A (en) Health capsule with energy invigorating and mind tranquillizing efficacies, and preparation method thereof
CN109481656A (en) A kind of drug for treating senile dementia
CN103908495B (en) Improve Chinese medicine composition and the method for making of tumor patient Postoperative Immunity function
CN102552619B (en) Medicine for treating tumor and preparation method thereof
CN105250951A (en) Preparing method for medicine for treating peptic ulcer
CN103860991B (en) Acute heart failure invigorating QI and tranquilization electuary and preparation method
CN105031389A (en) Traditional Chinese medicine tablet for restraining malignant tumor breeding in cooperation with radiotherapy and preparing method of traditional Chinese medicine tablet
CN105106712A (en) Nutritional porridge capable of helping postoperative recovery of cancer patient and preparation method thereof
CN115708861A (en) Formula of traditional Chinese medicine preparation
CN113082099A (en) Traditional Chinese medicine composition for treating hypertension by external application and preparation method and application thereof
CN111643630A (en) Five-element Chinese medicinal composition
CN115089660A (en) Traditional Chinese medicine formula suitable for regulating five internal organs, tonifying qi and tonifying kidney and preparation method
CN115317580A (en) Traditional Chinese medicine preparation for removing helicobacter pylori and preparation method thereof
CN111437372A (en) External composition formula for tonifying

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210402

RJ01 Rejection of invention patent application after publication